跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABIRAKIN TABLET 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
ABIRAKIN TABLET 250 MG
Approved
THERAPEUTIC
ABIRAKIN TABLET 250 MG
Aizant Drug Research Solutions Pvt Ltd
🇸🇬 Health Sciences Authority
Approval Date
Oct 5, 2020
Approval ID
69cf4a587d550c4f
Company
Aizant Drug Research Solutions Pvt Ltd
Type
Therapeutic
Approval Details
Approval Id
69cf4a587d550c4f
Drug Name
ABIRAKIN TABLET 250 MG
Product Name
ABIRAKIN TABLET 250 MG
Approval Number
SIN16021P
Approval Date
2020-10-05
Registrant
TRIKIN MARKETING PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
L02BX03
Atc Item Name
abiraterone
Pharma Manufacturer Name
trikin marketing private limited
Active Ingredients
Abiraterone acetate
250mg
Abiraterone acetate
250mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 5, 2020
Approval ID
69cf4a587d550c4f
Type
Therapeutic
Back to HSA Approvals